arrow
P

Pia Österlund

karolinska institutet
H指数:36
被引数:1.1万

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Treatment of localized rectal cancer in the Nordic countries—comparison of Nordic to Dutch, ESMO, and NCCN guidelines

北欧国家局部直肠癌的治疗——北欧指南与荷兰、ESMO及NCCN指南的比较

2026-07-200
PRE
Disease-phase-specific resource utilization and healthcare costs in metastatic colorectal cancer: a subgroup analysis of the finnish RAXO study

转移性结直肠癌各疾病阶段资源利用和医疗成本:芬兰RAXO研究的一个亚组分析

2025-11-010
PRE
KRAS and NRAS mutations in Nordic population-based and real-world metastatic colorectal cancer cohorts
2025-10-210
OAAI
Promoting large multinational academic clinical trials for gastrointestinal cancers in Europe: the ENGIC (European Network for GI Cancers) initiative

促进欧洲胃肠道癌症大型跨国学术临床研究:ENGIC(欧洲胃肠道癌症网络)倡议

2025-05-010
OA
Representation of geriatric oncology in cancer care guidelines in Europe: a scoping review by the International Society of Geriatric Oncology (SIOG)

欧洲癌症护理指南中老年肿瘤学的呈现:国际老年肿瘤学会(SIOG)的范畴综述

2025-05-010
PRE
Cost-utility of systemic anticancer therapy (SACT) with or without metastasectomy including local ablative therapy (LAT) for metastatic colorectal cancer (mCRC) patients

系统性抗肿瘤治疗(SACT)联合或未联合转移灶切除术(包括局部消融治疗,LAT)在转移性结直肠癌(mCRC)患者中的成本-效用分析

2024-09-010
PRE
The effect of BRAFV600E mutation on survival and treatment efficacy in vulnerable older patients with metastatic colorectal cancer - A post-hoc exploratory analysis of the randomized NORDIC9-studye

BRAFV600E突变对易受伤害的老年转移性结直肠癌患者的生存和治疗效果的影响-随机NORDIC9-studye的事后探索性分析

2024-03-010
OA
Impact of primary tumour sidedness (PTS) on demographics, resectability, and outcome after metastasectomy plus /- local ablative therapy (LAT), or systemic therapy in metastatic colorectal cancer patients (a RAXO substudy)
2023-10-010
OA
Atypical (non-V600E) BRAF mutations in metastatic colorectal cancer in population and real-world cohorts

人群和现实队列中转移性结直肠癌的非典型 (non-V600E) BRAF突变

2023-09-195
OA
The management of hepatocellular carcinoma. Current expert opinion and recommendations derived from the 24th ESMO/World Congress on Gastrointestinal Cancer, Barcelona, 2022
2023-06-0162
OAAI
Resectability, Resections, Survival Outcomes, and Quality of Life in Older Adult Patients with Metastatic Colorectal Cancer (the RAXO-Study)
2023-05-187
OAAI